Cedarburg Pharmaceuticals, Inc.
Records under this name other than the patents Cedarburg Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 2 of 2 · Back to Cedarburg Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,541,609 | Exemestane and its Intermediates and Methods of Making the Same No holder on record Term ended Term ended Jan 14, 2025 · High confidence | Term ended | Term ended Jan 14, 2025 | High confidence |
| US 7,321,064 | Preparation of Amides of Retinoic Acid via Mixed Anhydride and Mixed Carbonate Intermediates Lapsed on the fee record Ended Jan 22, 2020 · High confidence | Lapsed on the fee record | Ended Jan 22, 2020 | High confidence |